Table 9:

Other TAVI-related complications

Conversion to open surgery
  •  Conversion to open sternotomy during the TAVI procedure secondary to any procedure-related complications

Unplanned use of cardiopulmonary bypass (CPB)
  •  Unplanned use of CPB for haemodynamic support at any time during the TAVI procedure

Coronary obstruction
  •  Angiographic or echocardiographic evidence of a new, partial or complete, obstruction of a coronary ostium, either by the valve prosthesis itself, the native leaflets, calcifications, or dissection, occurring during or after the TAVI procedure

Ventricular septal perforation
  •  Angiographic or echocardiographic evidence of a new septal perforation during or after the TAVI procedure

Mitral valve apparatus damage or dysfunction
  •  Angiographic or echocardiographic evidence of new damage (chordae papillary muscle, or to the leaflet) to the mitral valve apparatus or dysfunction (e.g. restrictions due to the THV) of the mitral valve during or after the TAVI procedure

Cardiac tamponade
  •  Evidence of a new pericardial effusion associated with haemodynamic instability and clearly related to the TAVI procedure

Endocarditis
  •  Any one of the following

  •  Fulfilment of the Duke endocarditis criteriaa

  •  Evidence of abscess, paravalvular leak, pus, or vegetation confirmed as secondary to infection by histological or bacteriological studies during a re-operation

  •  Findings of abscess, pus, or vegetation involving a repaired or replaced valve during an autopsy

Valve thrombosis
  •  Any thrombus attached to or near an implanted valve that occludes part of the blood flow path, interferes with valve function, or is sufficiently large to warrant treatment. Note that valve-associated thrombus identified at autopsy in a patient whose cause of death was not valve-related should not be reported as valve thrombosis

Valve malpositioning
  •  Valve migration

    •  After initial correct positioning, the valve prosthesis moves upwards or downwards, within the aortic annulus from its initial position, with or without consequences

  •  Valve embolization

    •  The valve prosthesis moves during or after deployment such that it loses contact with the aortic annulus

  •  Ectopic valve deployment

    •  Permanent deployment of the valve prosthesis in a location other than the aortic root

TAV-in-TAV deployment
  •  An additional valve prosthesis is implanted within a previously implanted prosthesis because of suboptimal device position and/or function, during or after the index procedure

Conversion to open surgery
  •  Conversion to open sternotomy during the TAVI procedure secondary to any procedure-related complications

Unplanned use of cardiopulmonary bypass (CPB)
  •  Unplanned use of CPB for haemodynamic support at any time during the TAVI procedure

Coronary obstruction
  •  Angiographic or echocardiographic evidence of a new, partial or complete, obstruction of a coronary ostium, either by the valve prosthesis itself, the native leaflets, calcifications, or dissection, occurring during or after the TAVI procedure

Ventricular septal perforation
  •  Angiographic or echocardiographic evidence of a new septal perforation during or after the TAVI procedure

Mitral valve apparatus damage or dysfunction
  •  Angiographic or echocardiographic evidence of new damage (chordae papillary muscle, or to the leaflet) to the mitral valve apparatus or dysfunction (e.g. restrictions due to the THV) of the mitral valve during or after the TAVI procedure

Cardiac tamponade
  •  Evidence of a new pericardial effusion associated with haemodynamic instability and clearly related to the TAVI procedure

Endocarditis
  •  Any one of the following

  •  Fulfilment of the Duke endocarditis criteriaa

  •  Evidence of abscess, paravalvular leak, pus, or vegetation confirmed as secondary to infection by histological or bacteriological studies during a re-operation

  •  Findings of abscess, pus, or vegetation involving a repaired or replaced valve during an autopsy

Valve thrombosis
  •  Any thrombus attached to or near an implanted valve that occludes part of the blood flow path, interferes with valve function, or is sufficiently large to warrant treatment. Note that valve-associated thrombus identified at autopsy in a patient whose cause of death was not valve-related should not be reported as valve thrombosis

Valve malpositioning
  •  Valve migration

    •  After initial correct positioning, the valve prosthesis moves upwards or downwards, within the aortic annulus from its initial position, with or without consequences

  •  Valve embolization

    •  The valve prosthesis moves during or after deployment such that it loses contact with the aortic annulus

  •  Ectopic valve deployment

    •  Permanent deployment of the valve prosthesis in a location other than the aortic root

TAV-in-TAV deployment
  •  An additional valve prosthesis is implanted within a previously implanted prosthesis because of suboptimal device position and/or function, during or after the index procedure

TAVI: transcatheter aortic valve implantation; THV: transcatheter heart valve.

aDurack et al. [72].

Table 9:

Other TAVI-related complications

Conversion to open surgery
  •  Conversion to open sternotomy during the TAVI procedure secondary to any procedure-related complications

Unplanned use of cardiopulmonary bypass (CPB)
  •  Unplanned use of CPB for haemodynamic support at any time during the TAVI procedure

Coronary obstruction
  •  Angiographic or echocardiographic evidence of a new, partial or complete, obstruction of a coronary ostium, either by the valve prosthesis itself, the native leaflets, calcifications, or dissection, occurring during or after the TAVI procedure

Ventricular septal perforation
  •  Angiographic or echocardiographic evidence of a new septal perforation during or after the TAVI procedure

Mitral valve apparatus damage or dysfunction
  •  Angiographic or echocardiographic evidence of new damage (chordae papillary muscle, or to the leaflet) to the mitral valve apparatus or dysfunction (e.g. restrictions due to the THV) of the mitral valve during or after the TAVI procedure

Cardiac tamponade
  •  Evidence of a new pericardial effusion associated with haemodynamic instability and clearly related to the TAVI procedure

Endocarditis
  •  Any one of the following

  •  Fulfilment of the Duke endocarditis criteriaa

  •  Evidence of abscess, paravalvular leak, pus, or vegetation confirmed as secondary to infection by histological or bacteriological studies during a re-operation

  •  Findings of abscess, pus, or vegetation involving a repaired or replaced valve during an autopsy

Valve thrombosis
  •  Any thrombus attached to or near an implanted valve that occludes part of the blood flow path, interferes with valve function, or is sufficiently large to warrant treatment. Note that valve-associated thrombus identified at autopsy in a patient whose cause of death was not valve-related should not be reported as valve thrombosis

Valve malpositioning
  •  Valve migration

    •  After initial correct positioning, the valve prosthesis moves upwards or downwards, within the aortic annulus from its initial position, with or without consequences

  •  Valve embolization

    •  The valve prosthesis moves during or after deployment such that it loses contact with the aortic annulus

  •  Ectopic valve deployment

    •  Permanent deployment of the valve prosthesis in a location other than the aortic root

TAV-in-TAV deployment
  •  An additional valve prosthesis is implanted within a previously implanted prosthesis because of suboptimal device position and/or function, during or after the index procedure

Conversion to open surgery
  •  Conversion to open sternotomy during the TAVI procedure secondary to any procedure-related complications

Unplanned use of cardiopulmonary bypass (CPB)
  •  Unplanned use of CPB for haemodynamic support at any time during the TAVI procedure

Coronary obstruction
  •  Angiographic or echocardiographic evidence of a new, partial or complete, obstruction of a coronary ostium, either by the valve prosthesis itself, the native leaflets, calcifications, or dissection, occurring during or after the TAVI procedure

Ventricular septal perforation
  •  Angiographic or echocardiographic evidence of a new septal perforation during or after the TAVI procedure

Mitral valve apparatus damage or dysfunction
  •  Angiographic or echocardiographic evidence of new damage (chordae papillary muscle, or to the leaflet) to the mitral valve apparatus or dysfunction (e.g. restrictions due to the THV) of the mitral valve during or after the TAVI procedure

Cardiac tamponade
  •  Evidence of a new pericardial effusion associated with haemodynamic instability and clearly related to the TAVI procedure

Endocarditis
  •  Any one of the following

  •  Fulfilment of the Duke endocarditis criteriaa

  •  Evidence of abscess, paravalvular leak, pus, or vegetation confirmed as secondary to infection by histological or bacteriological studies during a re-operation

  •  Findings of abscess, pus, or vegetation involving a repaired or replaced valve during an autopsy

Valve thrombosis
  •  Any thrombus attached to or near an implanted valve that occludes part of the blood flow path, interferes with valve function, or is sufficiently large to warrant treatment. Note that valve-associated thrombus identified at autopsy in a patient whose cause of death was not valve-related should not be reported as valve thrombosis

Valve malpositioning
  •  Valve migration

    •  After initial correct positioning, the valve prosthesis moves upwards or downwards, within the aortic annulus from its initial position, with or without consequences

  •  Valve embolization

    •  The valve prosthesis moves during or after deployment such that it loses contact with the aortic annulus

  •  Ectopic valve deployment

    •  Permanent deployment of the valve prosthesis in a location other than the aortic root

TAV-in-TAV deployment
  •  An additional valve prosthesis is implanted within a previously implanted prosthesis because of suboptimal device position and/or function, during or after the index procedure

TAVI: transcatheter aortic valve implantation; THV: transcatheter heart valve.

aDurack et al. [72].

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close